Home - Products - Others - Other Targets - 4,2-Dihydroxy-4-methoxychalcone

4,2-Dihydroxy-4-methoxychalcone

CAS No. 63529-06-6

4,2-Dihydroxy-4-methoxychalcone( —— )

Catalog No. M31592 CAS No. 63529-06-6

4,2'-Dihydroxy-4'-methoxychalcone shows allergy-preventive effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 603 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4,2-Dihydroxy-4-methoxychalcone
  • Note
    Research use only, not for human use.
  • Brief Description
    4,2'-Dihydroxy-4'-methoxychalcone shows allergy-preventive effects.
  • Description
    4,2'-Dihydroxy-4'-methoxychalcone shows allergy-preventive effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    63529-06-6
  • Formula Weight
    270.28
  • Molecular Formula
    C16H14O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BNP (1-32), rat TFA ...

    Acts as a cardiac hormone with a variety of biological actions including natriuresis, diuresis, vasorelaxation, and inhibition of renin and aldosterone secretion. It is thought to play a key role in cardiovascular homeostasis. Helps restore the body\'s salt and water balance. Improves heart function.

  • CFI-402257

    CFI-402257 is a orally active, and potent highly selective small-molecule inhibitor of Mps1 with Ki of 0.09 ± 0.02 nM.

  • MAGE-3 Antigen (168-...

    MAGE-3 peptide (MAGE-3 168-176, human) is a peptide encoded by human MAGE-3 gene, which is expressed in tumor cells, presented by HLA and recognized by cytolytic T lymphocytes (CTL) as tumor antigen.